Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zeyao Ye"'
Autor:
Jingquan Fang, Xingmao Huang, Xiangliu Chen, Qi Xu, Tengjiao Chai, Ling Huang, Han Chen, Hang Chen, Zeyao Ye, Yian Du, Pengfei Yu
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 17126-17138 (2023)
Abstract Background Ovarian metastasis from gastric cancer (GC) is characterized by aggressive biological behavior and poor outcome. Currently, there is no standard treatment mode for such patients. Thus, we evaluated the efficacy of conversion thera
Externí odkaz:
https://doaj.org/article/a85e3f21427448d392affeea8c35aef3
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background There is no currently available treatment for peritoneal metastasis of gastric cancer. This phase II study aimed to evaluate the efficacy and safety of neoadjuvant systemic chemotherapy and hyperthermic intraperitoneal chemotherap
Externí odkaz:
https://doaj.org/article/e9fe14e271564f979add2b0d1749a723
Autor:
Pengfei Yu, Guangyu Ding, Xingmao Huang, Chenxuan Wang, Jingquan Fang, Ling Huang, Zeyao Ye, Qi Xu, Xiaoying Wu, Junrong Yan, Qiuxiang Ou, Yian Du, Xiangdong Cheng
Publikováno v:
International Journal of Surgery; Jun2024, Vol. 110 Issue 6, p3504-3517, 14p
Autor:
Pengfei Yu, Xingmao Huang, Ling Huang, Gaiguo Dai, Qi Xu, Jingquan Fang, Zeyao Ye, Tengjiao Chai, Yian Du
Background: Currently, there is a lack of effective strategy for the prevention of peritoneal metastasis(PM) from locally advanced gastric cancer (AGC). This randomized controlled study aimed to evaluate the outcome of D2 radical resection with hyper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6c85773175f183f59bf0befff6a413f
https://doi.org/10.21203/rs.3.rs-2490302/v1
https://doi.org/10.21203/rs.3.rs-2490302/v1
Publikováno v:
Journal of Clinical Oncology. 40:e16012-e16012
e16012 Background: Gastric cancer is the fifth most common cancer in the world and the third leading cause of cancer death. At present, traditional chemotherapy is still the main treatment method of advanced gastric cancer, but the efficacy is limite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e762532918f4c4456edc2c9b2e9adb02
https://doi.org/10.1200/jco.2022.40.16_suppl.e16012
https://doi.org/10.1200/jco.2022.40.16_suppl.e16012
Autor:
Xingmao Huang, Yu Pengfei, Jingquan Fang, Yang Cao, Zeyao Ye, Tengjiao Chai, Yian Du, Xiangdong Cheng
Publikováno v:
Journal of Clinical Oncology. 40:e16064-e16064
e16064 Background: Borrmann type IV gastric cancer is highly malignant and prone to peritoneal metastasis, including peritoneal dissemination (P1) and positive peritoneal cytology (CY1) causing a dismal prognosis. This study is to compare the efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f05b758563ffcda987084e953cc4cdd
https://doi.org/10.1200/jco.2022.40.16_suppl.e16064
https://doi.org/10.1200/jco.2022.40.16_suppl.e16064
Publikováno v:
Journal of Clinical Oncology. 40:e16022-e16022
e16022 Background: Peritoneal metastasis is the most common metastatic mode of advanced gastric cancer, which is prone to poor prognosis and is also one of the common causes of death in patients with distant gastric cancer metastasis.The purpose of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f81cf079678e92cf74f24b16987b280
https://doi.org/10.1200/jco.2022.40.16_suppl.e16022
https://doi.org/10.1200/jco.2022.40.16_suppl.e16022
Publikováno v:
Journal of Clinical Oncology. 40:e16041-e16041
e16041 Background: Hepatic metastases of gastric cancer(HMGC) are an important factor affecting the prognosis of gastric cancer patients, and 3-14% of gastric cancer cases were diagnosed with synchronous hepatic metastases of gastric cancer (SHMGC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48562f1992ffe0711a72f6c93c3ad44d
https://doi.org/10.1200/jco.2022.40.16_suppl.e16041
https://doi.org/10.1200/jco.2022.40.16_suppl.e16041